PIERINI, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 2.600
AS - Asia 2.032
EU - Europa 1.783
SA - Sud America 404
AF - Africa 55
OC - Oceania 4
Totale 6.878
Nazione #
US - Stati Uniti d'America 2.534
SG - Singapore 970
IT - Italia 509
CN - Cina 345
BR - Brasile 307
IE - Irlanda 294
RU - Federazione Russa 247
HK - Hong Kong 231
VN - Vietnam 158
FR - Francia 136
DE - Germania 132
FI - Finlandia 110
KR - Corea 74
GB - Regno Unito 64
SE - Svezia 57
IN - India 52
UA - Ucraina 50
AT - Austria 46
BD - Bangladesh 45
TR - Turchia 31
AR - Argentina 29
CA - Canada 27
MX - Messico 25
PL - Polonia 25
NL - Olanda 23
EC - Ecuador 21
CZ - Repubblica Ceca 19
IQ - Iraq 18
PK - Pakistan 17
ZA - Sudafrica 16
CH - Svizzera 14
SA - Arabia Saudita 14
BE - Belgio 13
CO - Colombia 13
ID - Indonesia 11
JP - Giappone 11
VE - Venezuela 10
PH - Filippine 9
MA - Marocco 8
RO - Romania 8
MY - Malesia 7
CL - Cile 6
KE - Kenya 6
LT - Lituania 6
PE - Perù 6
ES - Italia 5
ET - Etiopia 5
IL - Israele 5
JO - Giordania 5
PT - Portogallo 5
UZ - Uzbekistan 5
NP - Nepal 4
AO - Angola 3
AU - Australia 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BO - Bolivia 3
DK - Danimarca 3
DZ - Algeria 3
GR - Grecia 3
HN - Honduras 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
NI - Nicaragua 3
OM - Oman 3
PY - Paraguay 3
TN - Tunisia 3
UY - Uruguay 3
EG - Egitto 2
GF - Guiana Francese 2
HR - Croazia 2
JM - Giamaica 2
KG - Kirghizistan 2
NG - Nigeria 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
CM - Camerun 1
CR - Costa Rica 1
DJ - Gibuti 1
DM - Dominica 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
IM - Isola di Man 1
KI - Kiribati 1
LV - Lettonia 1
ML - Mali 1
MM - Myanmar 1
MN - Mongolia 1
MR - Mauritania 1
MU - Mauritius 1
PA - Panama 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 6.875
Città #
Singapore 719
Dublin 294
San Jose 286
Chandler 253
San Mateo 240
Hong Kong 227
Ashburn 199
Perugia 182
Boardman 165
Santa Clara 113
Moscow 97
Beijing 77
Lauterbourg 76
Altamura 75
Seoul 74
Los Angeles 65
Munich 64
Andover 60
Medford 59
Princeton 58
Lawrence 55
Wilmington 53
Turku 51
Hanoi 45
Ho Chi Minh City 45
New York 44
Ann Arbor 38
Vienna 36
The Dalles 30
Piscataway 29
São Paulo 27
Helsinki 26
Frankfurt am Main 25
Rome 23
Des Moines 22
Redmond 20
San Paolo di Civitate 20
Bologna 19
London 19
Milan 19
Nuremberg 19
Jacksonville 18
Brooklyn 17
Council Bluffs 17
Warsaw 16
Hefei 15
Houston 15
Norwalk 15
Orem 15
Denver 14
Atlanta 13
Dearborn 13
Falls Church 13
Florence 13
Rio de Janeiro 13
Brno 12
Brussels 12
Dallas 12
Johannesburg 12
Phoenix 12
Boston 11
Chicago 11
Saint Petersburg 11
Amsterdam 10
Quito 10
Stockholm 10
Tokyo 10
Hải Dương 9
Lappeenranta 9
Terni 9
Baghdad 8
Groningen 8
Guangzhou 8
Montreal 8
Redwood City 8
West Jordan 8
Bucharest 7
Da Nang 7
Falkenstein 7
Izmir 7
Manchester 7
Marsciano 7
Poplar 7
Riyadh 7
Chennai 6
Foligno 6
Mexico City 6
Nairobi 6
Padova 6
San Francisco 6
Seattle 6
Secaucus 6
Ancona 5
Brasília 5
Buffalo 5
Kocaeli 5
Lima 5
Medellín 5
Mumbai 5
Shanghai 5
Totale 4.607
Nome #
NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models 143
Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity. 139
"Designed" grafts for HLA-haploidentical stem cell transplantation. 124
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 123
Clinical-Grade Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell Dependent Graft-versus-Leukemia Effect in Murine Models 123
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 120
TNFR2 signaling modulates immunity after allogeneic hematopoietic cell transplantation 120
Enhancing Regulatory T Cell Function and Homing to the Gut to Improve graft-versus-host Disease Prevention after Adoptive Transfer in Allogeneic Hematopoietic Transplantation 118
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 117
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 116
CD4+FOXP3+ Regulatory T Cell Therapies in HLA Haploidentical Hematopoietic Transplantation 116
CMV management with specific immunoglobulins: A multicentric retrospective analysis on 92 allotransplanted patients 113
Activation of Regulatory T Cells with IL-2 and TNF-alpha to Promote Homing to the Gut and to Improve Acute GvHD Prevention 111
T regulatory cell separation for clinical application. 110
Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35 107
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 106
Acute myeloid leukemia development soon after anti-CD19 chimeric antigen receptor T-cell infusion in a patient with refractory diffuse large B-cell lymphoma and pre-existing clonal hematopoiesis 104
Multi-institutional evaluation of MVCT guided patient registration and dosimetric precision in total marrow irradiation: A global health initiative by the international consortium of total marrow irradiation 104
Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients 102
HLA-MATCHED TREG/TCON ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION ENSURES REMARKABLE CHRONIC GVHD/LEUKEMIA FREE SURVIVAL IN HIGH-RISK LEUKEMIA PATIENTS 100
ADOPTIVE IMMUNOTHERAPY WITH REGULATORY AND CONVENTIONAL T CELLS AFFORDS HIGH RATE OF CHRONIC GVHD/RELAPSE-FREE SURVIVAL IN ACUTE MYELOID LEUKEMIA AFTER MYELOABLATIVE HAPLOIDENTICAL TRANSPLANTATION 98
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 97
T cell depletion and no post transplant immune suppression allow separation of graft versus leukemia from graft versus host disease 97
How Adoptive Immunotherapy with Conventional T and Regulatory T Cells Exerts a Gvl Effect without GvHD, after Haploidentical Hematopoietic Transplantation 96
The effect of TNF-α on regulatory T cell function in graft-versus-host disease 95
T cells expressing chimeric antigen receptor promote immune tolerance 93
TLR3 essentially promotes protective class I-restricted memory CD8+ T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients. 93
Acute GvHD after HLA- Haploidentical Hematopoietic Cell Transplantation with Regulatory and Conventional T Cell Immunotherapy Does Not Adversely Affect Transplantation Outcomes 92
Case Report: Subtotal Lymphoid and Total Marrow Irradiation as Bridge Therapy to CD19-Directed CAR T Cells in a Chemorefractory DLBCL With Leukemic Involvement 91
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces non-relapse mortality 91
The Leukemic Isocitrate Dehydrogenase (IDH) 1/2 Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs) 91
REGULATORY T CELL ADOPTIVE IMMUNOTHERAPY PROMOTES B CELL IMMUNITY AFTER HAPLOIDENTICAL TRANSPLANTATION 90
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 88
Foxp3+regulatory T cells maintain the bone marrow microenvironment for B cell lymphopoiesis 88
CD41 invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD41CD251FoxP31 regulatory T cells 88
New mechanism of lymphoma-induced bone marrow aplasia 87
Blinatumomab Redirects Donor Lymphocytes against CD19+ Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation 85
The “ultimate” haploidentical transplantation for the elderly with high-risk acute myeloid leukemia 85
Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease 81
Regulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantation 80
FISH analysis reveals frequent co-occurrence of 4q24/TET2 and 5q and/or 7q deletions. 79
NK cell reconstitution is improved during allogeneic hematopoietic stem cell transplantation by infusion of NK cell-committed progenitor cells (HEM5P. 233) 78
Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway 77
HLA-Matched Treg/Tcon Allogeneic Hematopoietic Cell Transplantation Is Safe and Ensures Remarkable Chronic GvHD/Leukemia Free Survival in High-Risk Leukemia Patients 76
Venetoclax plus azacitidine as genetic-driven bridge-to-transplant therapy for IDH2-mutated acute myeloid leukaemia (AML) refractory to intensive chemotherapy: proof-of-concept case reports 73
Chronic stimulation results in NK cell function impairment mediated by NKG2D 73
Rifaximin use favoured micafungin-resistant Candida spp. infections in recipients of allogeneic hematopoietic cell transplantation 73
Control of alloreactivity using transient expression of a monoclonal antibody directed chimeric antigen receptor in conventional and regulatory T cells 72
HAPLOIDENTICAL TRANSPLANTATION WITH TREG-TCON ADOPTIVE IMMUNOTHERAPY FOR THE CURE OF ACUTE MYELOID LEUKEMIA WITH HIGH-RISK CYTOGENETICS 71
Engraftment of Embryonic Stem Cells and Differentiated Progeny by Host Conditioning with Total Lymphoid Irradiation and Regulatory T Cells 71
DR3 signaling modulates the function of Foxp3+regulatory T cells and the severity of acute graft-versus-host disease 70
Impact of Donor T Cells on NK Cell Development after Allogeneic Hematopoietic Cell Transplantation 70
The Evolution of T Cell Depleted Haploidentical Transplantation 70
CD4+FoxP3+ Regulatory T Cells Promote B Cell Differentiation and Induce Tolerance to Bone Marrow Grafts 69
Mutational analisys of JAK2 VAL617PHE in a new series of chronic myelomonocytic leukemia and related atypical myeloproliferative disorders 68
Impact of total marrow/lymphoid irradiation dose to the intestine on graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for hematologic malignancies 67
Regulatory T Cell Adoptive Immunotherapy Promotes B Cell Immunity after Haploidentical Transplantation 67
Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia 67
CD4+FoxP3+Regulatory T Cells Regulate B Cell Differentiation and Induce Tolerance to Bone Marrow Grafts 66
HLA-haploidentical hematopoietic stem cells transplantation with regulatory and conventional T-cell adoptive immunotherapy in pediatric patients with very high-risk acute leukemia 66
Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host disease 65
NPM1 monoallelic deletion in a subgroup of MDS/AML with del(5q) or monosomy 5 and complex karyotype 63
Feasibility of a Novel Sparse Orthogonal Collimator–Based Preclinical Total Marrow Irradiation for Enhanced Dosimetric Conformality 62
Donor natural killer cells trigger production of beta-2-microglobulin to enhance post bone marrow transplant immunity 62
Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax 60
TREG/TCON immunotherapy promotes HSC-derived B lymphopoiesis and boosts B cell immunity after haploidentical transplantation 59
NPM1 haploinsufficiency in MDS/AML with del(5q)/monosomy 5 59
The Use of Monoclonal Antibody Directed Chimeric Antigen Receptors to Facilitate Conventional T Cell and Treg Control of GvHD and Tissue Tolerance in Murine Models 57
Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell Exhaustion 56
Host CD4+CD25+FoxP3+Regulatory T Cells Facilitate Donor Engraftment Without Impacting Graft Versus Host Disease Onset After Major-Mismatched Hematopoietic Stem Cell Transplantation 55
TNF-α priming enhances CD4+FoxP3+regulatory T-cell suppressive function in murine GVHD prevention and treatment 55
Venetoclax and Bortezomib in Relapsed/Refractory Early T-Cell Precursor Acute Lymphoblastic Leukemia 54
Total marrow irradiation reduces organ damage and enhances tissue repair with the potential to increase the targeted dose of bone marrow in both young and old mice 53
TNF-Alpha Priming Enhances CD4(+) FoxP3(+) Regulatory T Cell Suppressive Function in GvHD Prevention and Treatment 53
The Use of Monoclonal Antibody Directed Chimeric Antigen Receptors to Guide T Cell and Treg Homing for GvHD Control and Tissue Tolerance in Murine Models 52
Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation 51
Freeze and thaw of CD4+CD25+Foxp3+ regulatory T cells results in loss of CD62L expression and a reduced capacity to protect against graft-versus-host disease 50
NK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell Engraftment 49
TIM-1 Blockade of the Donor Graft Provides Protection Against Lethal Gvhd 48
Regulatory T Cell Immunotherapy in Immune-Mediated Diseases 47
Third Party Invariant Natural Killer T Cells Protect from Lethal Graft-Versus-Host Disease through Donor CD4+CD25+FoxP3+ Regulatory T Cells 46
TIM-1 blockade of the donor graft provides protection against lethal GVHD 46
Editorial: The Immunobiology of HLA-Haploidentical Hematopoietic Cell Transplantation 45
First Multimodal, Three-Dimensional, Image-Guided Total Marrow Irradiation Model for Preclinical Bone Marrow Transplantation Studies 44
TNF-Alpha Priming Enhances CD4+FoxP3+ Regulatory T Cell Suppressive Function in GVHD Prevention and Treatment 42
Mast cells suppress murine GVHD in a mechanism independent of CD4+ CD25+ regulatory T cells 39
How adoptive transfer of components of the donor immune system boosts GvL and prevents GvHD in HLA-haploidentical hematopoietic transplantation for acute leukemia 34
null 34
Role of donor regulatory T cell adoptive immunotherapy in B cell immunity after hematopoietic cell transplantation 29
null 27
Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality 21
Safety of 20Gy Total Marrow Irradiation Based Conditioning Regimen for Hematopoietic Cell Transplantation with T Cell Adoptive Immunotherapy 17
A Combination of Plerixafor and Filgrasting Promotes Successful CD34+ Cell Collection for CRISPR/Cas9 Therapy in Sickle Cell Disease Patients With Insufficient Response to Plerixafor Alone 13
CPX-351 Induces High Rate of Complete Remission in the New ICC/ELN 2022 Adverse-Risk Entity ‘AML with MDS-Related Gene Mutations’: Evidence from a Large Real-World Italian Study 8
Durable remission despite transplantation with active disease in therapy-related NUP98::TOP1-rearranged acute myeloid leukemia 3
Totale 7.103
Categoria #
all - tutte 34.323
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.323


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 0 4
2021/2022654 9 199 1 15 29 7 10 175 11 25 101 72
2022/2023947 63 212 12 53 62 91 5 39 335 11 48 16
2023/2024584 15 59 14 14 2 14 118 8 41 26 127 146
2024/20251.339 41 126 49 59 176 86 72 101 237 77 196 119
2025/20263.001 220 215 157 404 403 251 520 167 286 265 76 37
Totale 7.103